24 July 2026
The Extensior launch in South Africa offers 15% lower semaglutide prices, but Discovery Health says scheme coverage is unlikely to expand.
21 July 2026
The Extensior South Africa launch on 27 July, offering patients a lower-cost, authorised semaglutide treatment for type 2 diabetes.
16 July 2026
Sun Pharma’s Generic Semaglutide is now available in South Africa. Explore this new treatment option for type 2 diabetes.
25 June 2026
US prescription drug spending is forecast to exceed $560bn in 2026 as demand for GLP-1 obesity and diabetes treatments continues to rise.
23 June 2026
iDexis semaglutide ban stops the pharmacy group from selling compounded weight-loss medicines while SAHPRA and the SAPC investigate.
2 June 2026
The Semaglutide Compounding Dispute intensifies as Novo Nordisk takes iDexis to court over illegal manufacturing of weight-loss injections.
8 May 2026
Aspen Insulin approval marks a milestone for diabetes care in South Africa, ensuring supply security with locally made insulin.
23 March 2026
Learn how the advent of Generic Semaglutide in India will change the landscape of weight-loss and diabetes medications.
11 March 2026
Discover the potential of Generic Semaglutide Pricing, where new research shows significant savings on weight-loss medications.
9 February 2026
8 January 2026
Explore the benefits of the Wegovy weight-loss pill as a revolutionary option in managing obesity effectively.
22 August 2025
Novo Nordisk implements a hiring freeze as layoffs approach after Wegovy's success. Discover the impact on the pharmaceutical industry.